Cargando…
Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma
BACKGROUND: The molecular mechanisms involved in the development and progression of clear cell renal cell carcinomas (ccRCCs) are poorly understood. The objective of this study was to analyze the expression of dual-specificity phosphatase 9 (DUSP-9) and determine its clinical significance in human c...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198720/ https://www.ncbi.nlm.nih.gov/pubmed/21943117 http://dx.doi.org/10.1186/1471-2407-11-413 |
_version_ | 1782214479249932288 |
---|---|
author | Wu, Song Wang, Yong Sun, Liang Zhang, Zhiling Jiang, Zhimao Qin, Zike Han, Hui Liu, Zhuowei Li, Xianxin Tang, Aifa Gui, Yaoting Cai, Zhiming Zhou, Fangjian |
author_facet | Wu, Song Wang, Yong Sun, Liang Zhang, Zhiling Jiang, Zhimao Qin, Zike Han, Hui Liu, Zhuowei Li, Xianxin Tang, Aifa Gui, Yaoting Cai, Zhiming Zhou, Fangjian |
author_sort | Wu, Song |
collection | PubMed |
description | BACKGROUND: The molecular mechanisms involved in the development and progression of clear cell renal cell carcinomas (ccRCCs) are poorly understood. The objective of this study was to analyze the expression of dual-specificity phosphatase 9 (DUSP-9) and determine its clinical significance in human ccRCCs. METHODS: The expression of DUSP-9 mRNA was determined in 46 paired samples of ccRCCs and adjacent normal tissues by using real-time qPCR. The expression of the DUSP-9 was determined in 211 samples of ccRCCs and 107 paired samples of adjacent normal tissues by immunohistochemical analysis. Statistical analysis was performed to define the relationship between the expression of DUSP-9 and the clinical features of ccRCC. RESULTS: The mRNA level of DUSP-9, which was determined by real-time RT-PCR, was found to be significantly lower in tumorous tissues than in the adjacent non-tumorous tissues (p < 0.001). An immunohistochemical analysis of 107 paired tissue specimens showed that the DUSP-9 expression was lower in tumorous tissues than in the adjacent non-tumorous tissues (p < 0.001). Moreover, there was a significant correlation between the DUSP-9 expression in ccRCCs and gender (p = 0.031), tumor size (p = 0.001), pathologic stage (p = 0.001), Fuhrman grade (p = 0.002), T stage (p = 0.001), N classification (p = 0.012), metastasis (p = 0.005), and recurrence (p < 0.001). Patients with lower DUSP-9 expression had shorter overall survival time than those with higher DUSP-9 expression (p < 0.001). Multivariate analysis indicated that low expression of the DUSP-9 was an independent predictor for poor survival of ccRCC patients. CONCLUSION: To our knowledge, this is the first study that determines the relationship between DUSP-9 expression and prognosis in ccRCC. We found that decreased expression of DUSP-9 is associated with poor prognosis in ccRCC. DUSP-9 may represent a novel and useful prognostic marker for ccRCC. |
format | Online Article Text |
id | pubmed-3198720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31987202011-10-23 Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma Wu, Song Wang, Yong Sun, Liang Zhang, Zhiling Jiang, Zhimao Qin, Zike Han, Hui Liu, Zhuowei Li, Xianxin Tang, Aifa Gui, Yaoting Cai, Zhiming Zhou, Fangjian BMC Cancer Research Article BACKGROUND: The molecular mechanisms involved in the development and progression of clear cell renal cell carcinomas (ccRCCs) are poorly understood. The objective of this study was to analyze the expression of dual-specificity phosphatase 9 (DUSP-9) and determine its clinical significance in human ccRCCs. METHODS: The expression of DUSP-9 mRNA was determined in 46 paired samples of ccRCCs and adjacent normal tissues by using real-time qPCR. The expression of the DUSP-9 was determined in 211 samples of ccRCCs and 107 paired samples of adjacent normal tissues by immunohistochemical analysis. Statistical analysis was performed to define the relationship between the expression of DUSP-9 and the clinical features of ccRCC. RESULTS: The mRNA level of DUSP-9, which was determined by real-time RT-PCR, was found to be significantly lower in tumorous tissues than in the adjacent non-tumorous tissues (p < 0.001). An immunohistochemical analysis of 107 paired tissue specimens showed that the DUSP-9 expression was lower in tumorous tissues than in the adjacent non-tumorous tissues (p < 0.001). Moreover, there was a significant correlation between the DUSP-9 expression in ccRCCs and gender (p = 0.031), tumor size (p = 0.001), pathologic stage (p = 0.001), Fuhrman grade (p = 0.002), T stage (p = 0.001), N classification (p = 0.012), metastasis (p = 0.005), and recurrence (p < 0.001). Patients with lower DUSP-9 expression had shorter overall survival time than those with higher DUSP-9 expression (p < 0.001). Multivariate analysis indicated that low expression of the DUSP-9 was an independent predictor for poor survival of ccRCC patients. CONCLUSION: To our knowledge, this is the first study that determines the relationship between DUSP-9 expression and prognosis in ccRCC. We found that decreased expression of DUSP-9 is associated with poor prognosis in ccRCC. DUSP-9 may represent a novel and useful prognostic marker for ccRCC. BioMed Central 2011-09-26 /pmc/articles/PMC3198720/ /pubmed/21943117 http://dx.doi.org/10.1186/1471-2407-11-413 Text en Copyright ©2011 Wu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wu, Song Wang, Yong Sun, Liang Zhang, Zhiling Jiang, Zhimao Qin, Zike Han, Hui Liu, Zhuowei Li, Xianxin Tang, Aifa Gui, Yaoting Cai, Zhiming Zhou, Fangjian Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
title | Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
title_full | Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
title_fullStr | Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
title_full_unstemmed | Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
title_short | Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
title_sort | decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198720/ https://www.ncbi.nlm.nih.gov/pubmed/21943117 http://dx.doi.org/10.1186/1471-2407-11-413 |
work_keys_str_mv | AT wusong decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT wangyong decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT sunliang decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT zhangzhiling decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT jiangzhimao decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT qinzike decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT hanhui decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT liuzhuowei decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT lixianxin decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT tangaifa decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT guiyaoting decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT caizhiming decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma AT zhoufangjian decreasedexpressionofdualspecificityphosphatase9isassociatedwithpoorprognosisinclearcellrenalcellcarcinoma |